Investing Profile

Fei Shen

InvestorVC
Managing Director at Boehringer Ingelheim Venture Fund
boehringer-ingelheim-venture....Cambridge, Massachusetts
Photo of Fei Shen, Managing Director at Boehringer Ingelheim Venture Fund
cb
$3.3M - $17.0M
$8.5M
2
CompanyStageDateRound SizeTotal Raised
Rgenta Therapeutics
Series ANov 2022$52M
$90M
Co-investors: Martin Heidecker (AMR Action Fund), Hongbo Lu (Vivo Capital)
ArrePath
SeedMar 2022$20M
$20M
Co-investors: Dylan Morris (Insight Partners), Venkat Srinivasan (Innospark Ventures)